GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Compound class:
Peptide
Comment: CID-078 is an orally bioavailable macrocyclic peptide molecule, optimised for clinical application from the experimental macrocycle CIRc-014. Like its parent, CID-078 disrupts the protein-protein interactions between cyclins A and B and their cognate cyclin-dependent kinases (CDKs), as an anti-tumpour mechanism. The peptide binds to the same RxL motif within the conserved hydrophobic patch on the surface of the cyclins as CIRc-014.
|
|
|||||||||||||||||
| Bioactivity Comments |
| CID-078-mediated actions cause DNA damage, cell cycle arrest, and apoptosis in target tumour cells [1]. |
| Selectivity at other protein targets | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Key to terms and symbols | Click column headers to sort | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||